Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis

Overview of attention for article published in Virology Journal, September 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 18,170 followers.

RT @AurelioOrta: In this meta-analysis LAM plus TDF combination therapy was more efficacious than LAM monotherapy in HBV/HIV coinfected pat…

24 Sep 2018

Reply Repost Favourite

In this meta-analysis LAM plus TDF combination therapy was more efficacious than LAM monotherapy in HBV/HIV coinfected patients @VirologyJ https://t.co/wmUB0vsFgE

24 Sep 2018

Reply Repost Favourite

RT @VirologyJ: Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis https:/…

11 Sep 2018

Reply Repost Favourite

Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis https://t.co/gd9LgYpXS6

11 Sep 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.